Characterising methamphetamine use to inform health and social policies in Manitoba, Canada: a protocol for a retrospective cohort study using linked administrative data

被引:5
作者
Nickel, Nathan C. [1 ,2 ]
Enns, Jennifer E. [3 ]
Freier, Amy [3 ]
McCulloch, Scott C. [3 ]
Chartier, Mariette [3 ]
Casidsid, Hera J. M. [3 ]
Balogun, Oludolapo Deborah [3 ]
Mulhall, Drew [4 ]
Dragan, Roxana [3 ]
Sarkar, Joykrishna [3 ]
Bolton, James [5 ]
Konrad, Geoffrey [5 ]
Phillips-Beck, Wanda [6 ]
Sanguins, Julianne [7 ]
Shimmin, Carolyn [8 ]
McDonald, Neil [9 ]
Mignone, Javier [1 ]
Hinds, Aynslie [1 ]
机构
[1] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada
[2] Manitoba Inuit Assoc, Winnipeg, MB, Canada
[3] Univ Manitoba, Manitoba Ctr Hlth Policy, Winnipeg, MB, Canada
[4] Univ Manitoba, Dept Orthoped Surg, Winnipeg, MB, Canada
[5] Univ Manitoba, Dept Psychiat, Winnipeg, MB, Canada
[6] First Nations Hlth & Social Secretariat Manitoba, Winnipeg, MB, Canada
[7] Manitoba Metis Federat, Winnipeg, MB, Canada
[8] George & Fay Yee Ctr Healthcare Innovat, Winnipeg, MB, Canada
[9] Winnipeg Fire Paramed Serv, Winnipeg, MB, Canada
来源
BMJ OPEN | 2022年 / 12卷 / 10期
关键词
epidemiology; mental health; substance misuse; OPIOID OVERDOSE; MENTAL-HEALTH; PHARMACOTHERAPY; DEPENDENCE; MORTALITY; DEATH; AMPHETAMINE; MANAGEMENT; INDIVIDUALS; POPULATION;
D O I
10.1136/bmjopen-2022-062127
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Rising use of methamphetamine is causing significant public health concern in Canada. The biological and behavioural effects of methamphetamine range from wakefulness, vigour and euphoria to adverse physical health outcomes like myocardial infarction, haemorrhagic stroke, arrhythmia and seizure. It can also cause severe psychological complications such as psychosis. National survey data point to increasing rates of methamphetamine use, as well as increasing ease of access and serious methamphetamine-related harms. There is an urgent need for evidence to address knowledge gaps, provide direction to harm reduction and treatment efforts and inform health and social policies for people using methamphetamine. This protocol describes a study that aims to address this need for evidence. Methods The study will use linked, whole population, de-identified administrative data from the Manitoba Population Research Data Repository. The cohort will include individuals in the city of Winnipeg, Manitoba, who came into contact with the health system for reasons related to methamphetamine use from 2013 to 2021 and a comparison group matched on age, sex and geography. We will describe the cohort's sociodemographic characteristics, calculate incidence and prevalence of mental disorders associated with methamphetamine use and examine rates of health and social service use. We will evaluate the use of olanzapine pharmacotherapy in reducing adverse emergency department outcomes. In partnership with Indigenous co-investigators, outcomes will be stratified by First Nations and Metis identity. Ethics and dissemination The study was approved by the University of Manitoba Health Research Ethics Board, and access datasets have been granted by all data providers. We also received approval from the First Nations Health and Social Secretariat of Manitoba's Health Information Research Governance Committee and the Manitoba Metis Federation. Dissemination will be guided by an 'Evidence 2 Action' group of public rightsholders, service providers and knowledge users who will ensure that the analyses address the critical issues.
引用
收藏
页数:11
相关论文
共 67 条
  • [11] The burden and management of crystal meth use
    Buxton, Jane A.
    Dove, Naomi A.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2008, 178 (12) : 1537 - 1539
  • [12] All-cause mortality among individuals with disorders related to the use of methamphetamine: A comparative cohort study
    Callaghan, Russell C.
    Cunningham, James K.
    Verdichevski, Marina
    Sykes, Jenna
    Jaffer, Sukaina R.
    Kish, Stephen J.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2012, 125 (03) : 290 - 294
  • [13] Canadian Centre on Substance Use and Addiction, 2020, METHAMPHETAMINE CANA
  • [14] Canadian Centre on Substance Use and Addiction, 2019, CHANGES STIMULANT US
  • [15] Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis
    Chan, Brian
    Freeman, Michele
    Kondo, Karli
    Ayers, Chelsea
    Montgomery, Jessica
    Paynter, Robin
    Kansagara, Devan
    [J]. ADDICTION, 2019, 114 (12) : 2122 - 2136
  • [16] Colonialism as a Broader Social Determinant of Health
    Czyzewski, Karina
    [J]. INTERNATIONAL INDIGENOUS POLICY JOURNAL, 2011, 2 (01)
  • [17] Major physical and psychological harms of methamphetamine use
    Darke, Shane
    Kaye, Sharlene
    McKetin, Rebecca
    Duflou, Johan
    [J]. DRUG AND ALCOHOL REVIEW, 2008, 27 (03) : 253 - 262
  • [18] Prevalence and nature of cardiovascular disease in methamphetamine-related death: A national study
    Darke, Shane
    Duflou, Johan
    Kaye, Sharlene
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2017, 179 : 174 - 179
  • [19] Davey Caitlin J, 2014, J Ethn Subst Abuse, V13, P315, DOI 10.1080/15332640.2014.938211
  • [20] Drug overdose in the ED: a record linkage study examining emergency department ICD-10 coding practices in a cohort of people who inject drugs
    Di Rico, Rehana
    Nambiar, Dhanya
    Stoove, Mark
    Dietze, Paul
    [J]. BMC HEALTH SERVICES RESEARCH, 2018, 18